1. Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment
   Renyong Guo et al, 2016, Sci Rep CrossRef
2. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation
   Ayman M. Mahmoud, 2014, Can. J. Physiol. Pharmacol. CrossRef